Belite Bio BLTE
NASDAQ BLTE
$186.32 +15.23 (+8.90%)
As of: Sep 4, 2026 · 2:41 PM EDT

Belite Bio (BLTE) Interest & Investment Income (2024 - 2025)

Analysis

Belite Bio (BLTE) Interest & Investment Income (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 138.74 Bn 130.89 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.52 Bn 77.52 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 48.00 Mn
4 Moderna 58.04 Bn 52.91 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.06 Bn 44.06 Bn - 35.58 Mn
6 BeOne Medicines 39.98 Bn 34.88 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.46 Bn 32.15 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn - 5.13 Mn
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn 10.98 Mn
10 Belite Bio 6.25 Bn 6.25 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.17 Mn
Dec 31, 2024 1.24 Mn